BIOMAT Database Logo BIOMAT Database Logo

Enhanced cytotoxic response of natural killer cells to interleukin-2 in Alzheimer's disease. 1996

S B Solerte, and M Fioravanti, and S Severgnini, and M Locatelli, and M Renzullo, and N Pezza, and N Cerutti, and E Ferrari
Department of Internal Medicine, Geriatric and Gerontology Clinic, University of Pavia, Italy.

Experimental data suggest an involvement of immune cellular components in the development of Alzheimer's disease (AD). Against this background, the spontaneous natural killer (NK) cell activity and the NK-induced cytotoxicity after interleukin-2 (IL-2) were studied in healthy elderly subjects and in patients with dementia of Alzheimer type (SDAT) and multi-infarct type (MID). Higher NK cytotoxicity (expressed as total lysis and percent increase) at different IL-2 concentrations (50 and 100 IU/ml/cells) was demonstrated in patients with SDAT than in healthy elderly subjects (p < 0.001) and MID patients (p < 0.001). NK cell activity of MID patients was similar to that of healthy elderly and healthy young subjects. A negative correlation between the percent increase in NK cytotoxicity after IL-2 and the Mini Mental State Examination Score was also found in SDAT patients (p < 0.01). Alterations of IL-2-mediated NK cytotoxicity may therefore support the neuroimmune hypothesis of AD.

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008297 Male Males
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

S B Solerte, and M Fioravanti, and S Severgnini, and M Locatelli, and M Renzullo, and N Pezza, and N Cerutti, and E Ferrari
The response of human natural killer cells to interleukin-2.
January 2004, Journal of endocrinological investigation,
S B Solerte, and M Fioravanti, and S Severgnini, and M Locatelli, and M Renzullo, and N Pezza, and N Cerutti, and E Ferrari
Response of resting human peripheral blood natural killer cells to interleukin 2.
October 1984, The Journal of experimental medicine,
S B Solerte, and M Fioravanti, and S Severgnini, and M Locatelli, and M Renzullo, and N Pezza, and N Cerutti, and E Ferrari
[Natural killer (NK) cells and interleukin 2 (IL-2) in Crohn disease].
August 1990, Revista espanola de enfermedades digestivas,
S B Solerte, and M Fioravanti, and S Severgnini, and M Locatelli, and M Renzullo, and N Pezza, and N Cerutti, and E Ferrari
Cytotoxic activity against HIV-infected monocytes by recombinant interleukin 2-activated natural killer cells.
August 1990, AIDS research and human retroviruses,
S B Solerte, and M Fioravanti, and S Severgnini, and M Locatelli, and M Renzullo, and N Pezza, and N Cerutti, and E Ferrari
Selective growth of natural cytotoxic but not natural killer effector cells in interleukin-3.
January 1983, Nature,
S B Solerte, and M Fioravanti, and S Severgnini, and M Locatelli, and M Renzullo, and N Pezza, and N Cerutti, and E Ferrari
Enhancement of cytotoxic activity of natural killer cells by interleukin 2, and antagonism between interleukin 2 and adenosine cyclic monophosphate.
October 1985, Scandinavian journal of immunology,
S B Solerte, and M Fioravanti, and S Severgnini, and M Locatelli, and M Renzullo, and N Pezza, and N Cerutti, and E Ferrari
The role of natural killer cells in Alzheimer's disease.
November 2012, Scandinavian journal of immunology,
S B Solerte, and M Fioravanti, and S Severgnini, and M Locatelli, and M Renzullo, and N Pezza, and N Cerutti, and E Ferrari
Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.
October 2007, The Journal of urology,
S B Solerte, and M Fioravanti, and S Severgnini, and M Locatelli, and M Renzullo, and N Pezza, and N Cerutti, and E Ferrari
Interleukin-2 enhances the cytotoxic activity of circulating natural killer cells in patients with chronic heart failure.
July 2009, Heart and vessels,
S B Solerte, and M Fioravanti, and S Severgnini, and M Locatelli, and M Renzullo, and N Pezza, and N Cerutti, and E Ferrari
Immunological characterization of human decidual mononuclear cells: natural killer activity, response to interleukin-2 and distribution of interleukin-2 receptor subunits.
March 1994, Asia-Oceania journal of obstetrics and gynaecology,
Copied contents to your clipboard!